Guardian Pharmacy Services Stock Market Value
| GRDN Stock | 33.43 0.03 0.09% |
| Symbol | Guardian |
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets | Return On Equity |
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Guardian Pharmacy 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Guardian Pharmacy's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Guardian Pharmacy.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Guardian Pharmacy on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Guardian Pharmacy Services or generate 0.0% return on investment in Guardian Pharmacy over 90 days. Guardian Pharmacy is related to or competes with 10X Genomics, Procept Biorobotics, Twist Bioscience, Nuvation Bio, National HealthCare, Quidel, and Mednax. Guardian Pharmacy is entity of United States More
Guardian Pharmacy Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Guardian Pharmacy's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Guardian Pharmacy Services upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.59 | |||
| Information Ratio | 0.0534 | |||
| Maximum Drawdown | 13.96 | |||
| Value At Risk | (3.83) | |||
| Potential Upside | 4.77 |
Guardian Pharmacy Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guardian Pharmacy's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Guardian Pharmacy's standard deviation. In reality, there are many statistical measures that can use Guardian Pharmacy historical prices to predict the future Guardian Pharmacy's volatility.| Risk Adjusted Performance | 0.0709 | |||
| Jensen Alpha | 0.1151 | |||
| Total Risk Alpha | 0.0034 | |||
| Sortino Ratio | 0.0556 | |||
| Treynor Ratio | 0.1373 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardian Pharmacy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardian Pharmacy February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0709 | |||
| Market Risk Adjusted Performance | 0.1473 | |||
| Mean Deviation | 2.05 | |||
| Semi Deviation | 2.47 | |||
| Downside Deviation | 2.59 | |||
| Coefficient Of Variation | 1262.22 | |||
| Standard Deviation | 2.7 | |||
| Variance | 7.31 | |||
| Information Ratio | 0.0534 | |||
| Jensen Alpha | 0.1151 | |||
| Total Risk Alpha | 0.0034 | |||
| Sortino Ratio | 0.0556 | |||
| Treynor Ratio | 0.1373 | |||
| Maximum Drawdown | 13.96 | |||
| Value At Risk | (3.83) | |||
| Potential Upside | 4.77 | |||
| Downside Variance | 6.73 | |||
| Semi Variance | 6.11 | |||
| Expected Short fall | (2.26) | |||
| Skewness | (0.08) | |||
| Kurtosis | 0.8867 |
Guardian Pharmacy Backtested Returns
Guardian Pharmacy appears to be very steady, given 3 months investment horizon. Guardian Pharmacy holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Guardian Pharmacy, which you can use to evaluate the volatility of the firm. Please utilize Guardian Pharmacy's risk adjusted performance of 0.0709, and Market Risk Adjusted Performance of 0.1473 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Guardian Pharmacy holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 1.49, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Guardian Pharmacy will likely underperform. Please check Guardian Pharmacy's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Guardian Pharmacy's current trending patterns will revert.
Auto-correlation | 0.44 |
Average predictability
Guardian Pharmacy Services has average predictability. Overlapping area represents the amount of predictability between Guardian Pharmacy time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Guardian Pharmacy price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Guardian Pharmacy price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 3.06 |
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving together with Guardian Stock
Moving against Guardian Stock
| 0.62 | 3GX | HF FOODS GRP | PairCorr |
| 0.42 | P5F | Performance Food | PairCorr |
| 0.42 | MRU | Metro Inc | PairCorr |
| 0.39 | HITI | High Tide | PairCorr |
| 0.33 | GO | Grocery Outlet Holding | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Guardian Pharmacy Correlation, Guardian Pharmacy Volatility and Guardian Pharmacy Performance module to complement your research on Guardian Pharmacy. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Guardian Pharmacy technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.